吉利德科学再投资110亿美元扩充美国药厂设施

金融界
08 May

美国生化药厂吉利德科学公布,将投资110亿美元在美国增建更多制药及研究中心。公司表示,相关投资将是在原先已公布的210亿美元投资之上额外增加,主要用以兴建三幢新厂房及提升现有三间工厂,以及引入更先进科技。上述计划预期在2030年前完成。

吉利德估计,110亿美元的新投资可望在2028年前,创设至少800个新职位及2200个间接职位,为美国带来430亿美元经济效益。总统特朗普提出可能向进口药品开征关税后,包括礼来强生、默克等多间大药厂,先后公布在美国作出新投资的消息。

责任编辑:栎树

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10